OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 61 filers reported holding OVID THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $26,040 | -23.4% | 14,000 | -23.5% | 0.00% | – |
| Q3 2022 | $34,000 | -33.3% | 18,300 | -23.1% | 0.00% | – |
| Q2 2022 | $51,000 | -52.8% | 23,800 | -30.8% | 0.00% | – |
| Q1 2022 | $108,000 | -28.5% | 34,400 | -27.0% | 0.00% | – |
| Q4 2021 | $151,000 | -58.4% | 47,100 | -56.4% | 0.00% | -100.0% |
| Q3 2021 | $363,000 | -72.1% | 108,000 | -67.5% | 0.00% | -66.7% |
| Q2 2021 | $1,299,000 | +1.1% | 332,200 | +3.9% | 0.00% | -25.0% |
| Q1 2021 | $1,285,000 | -6.3% | 319,600 | -46.1% | 0.00% | 0.0% |
| Q4 2020 | $1,371,000 | +42.1% | 593,400 | +252.8% | 0.00% | +33.3% |
| Q3 2020 | $965,000 | +1278.6% | 168,200 | +618.8% | 0.00% | – |
| Q1 2020 | $70,000 | -12.5% | 23,400 | +21.9% | 0.00% | – |
| Q4 2019 | $80,000 | – | 19,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $407,000 | 0.69% |
| BVF INC/IL | 3,293,000 | $5,829,000 | 0.65% |
| COWEN INC. | 1,101,414 | $1,950,000 | 0.21% |
| ARMISTICE CAPITAL, LLC | 1,780,000 | $3,151,000 | 0.17% |
| Granite Point Capital Management, L.P. | 417,857 | $740,000 | 0.07% |
| Redmile Group, LLC | 737,550 | $1,305,000 | 0.04% |
| Tekla Capital Management LLC | 496,977 | $880,000 | 0.04% |
| Fairpointe Capital LLC | 101,000 | $179,000 | 0.01% |
| Alyeska Investment Group, L.P. | 225,000 | $398,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,440 | $149,000 | 0.00% |